https://www.asiafitnesstoday.com/foresee-pharmaceuticals-announces-results-from-a-phase-1-clinical-study-highlighting-promising-safety-tolerability-and-pharmacokinetic-profile-of-fp-045-a-potent-aldh2-activator/?lang=ms